12 Results (Page 1 of 1)
Brazil Free Sample Markets Research Reports
Brazil Orphan Disease Drugs Market Analysis Sample Report
Brazil's Orphan Diseases Drugs Market is projected to grow from $3.870 Bn in 2022 to $9.114 Bn by 2030, registering a CAGR of 11.30% during the forecast period of 2022-2030. In Brazil, there is a significant population affected by rare diseases, with estimates suggesting that around 8 Mn Brazilians suffer from one of the more than 7,000 rare diseases currently known. The most common types of rare diseases in Brazil include genetic disorders, neurological conditions, and blood disorders. The key players in the Brazil orphan diseases drugs market include Pfizer, Roche Holding, Sanofi, Novartis International, Merck, and Amgen.
Brazil Nutritional Supplements Market Analysis Sample Report
By 2030, it is anticipated that the Brazil Nutrition and Supplements market will reach a value of $19.71 Bn from $9.54 Bn in 2022, growing at a CAGR of 9.5% during 2022-30. The market is primarily dominated by local players such as Herbarium, Biofield, and Bioenergy. The market for nutrition and supplements in Brazil is primarily driven by government initiatives, increasing consumer awareness for health and lifestyle and sports nutrition supplements. The Brazil nutrition and supplements market in Brazil is segmented by Type, Product, application, and Distribution Channel.
Brazil Dermatology Drugs Market Analysis Sample Report
By 2030, it is anticipated that the Brazil dermatology drugs market will reach a value of $1037.35 Mn from $425 Mn in 2022, growing at a CAGR of 11.8% during 2022-2030. The market is primarily dominated by local players such as Neo Química, Eurofarma, and EMS S.A. The market is driven by Telemedicine, OTC, and government regulations. The dermatology drug market in Brazil is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel.
Brazil Biosimilars Market Analysis Sample Report
Brazil Biosimilars Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Cost-effectiveness, patent expirations of reference biologics, increasing demand for biologic medicines, a supportive regulatory environment, and increased acceptance by healthcare professionals are all main drivers in the biosimilars market. Novartis AG, Pfizer Inc., Amgen Inc., Coherus Biosciences Inc., Mylan NV (Viatris Inc.), and Samsung Bioepis Co., Ltd. are among the top competitors in the studied market.
Brazil Clinical Trials Support Service Market Analysis Sample Report
This report presents a strategic analysis of the Brazil Clinical Trials Support Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Clinical Trials Support Service Market, offering unmatched value, accuracy and expert insights.
Brazil Healthcare Insurance Market Analysis Sample Report
Brazil's healthcare insurance market is projected to grow from $50.66 Bn in 2022 to $98.01 Bn by 2030, registering a CAGR of 8.6% during the forecast period of 2022-2030. The main factors driving the growth would be increasing demand for private healthcare services, economic growth and rising income, regulatory reforms and technological advancements. The market is segmented by component, the provider, coverage, health insurance plans and end-user. Some of the major players include Bradesco Saude, Amil International Medical Assistance, Hapvida Sistema, Porto Seguro and Allianz.
Brazil Oncology Drugs Market Analysis Sample Report
By 2030, it is anticipated that the Brazil oncology drugs market will reach a value of $12.7 Bn from $4.9 Bn in 2022, growing at a CAGR of 12.6% during 2022-2030. The oncology drug market in Brazil is dominated by a few large pharmaceutical companies such as EMS Pharma, Eurofarma, and Takeda Pharma. The oncology market in Brazil is segmented by different therapeutic areas and by different treatment types. The major factors affecting the Brazilian oncology drugs market are the high cost of the drugs, and the structured reimbursement system for the treatment.
Brazil Digital Health Market Analysis Sample Report
The Brazil Digital Health market is projected to grow from $5.28 Bn in 2022 to $22.08 Bn by 2030, registering a CAGR of 19.6% during the forecast period of 2022 - 2030. Driven by the increasing prevalence of chronic diseases and the penetration of smartphones the market is expected to grow in the near future. The market is segmented by solution, deployment, and by end-use. Some of the major players include WeCancer Technological Solutions Ltd., Memed & Conexa Saúde.
Brazil Telemedicine Market Analysis Sample Report
Brazil telemedicine market is projected to grow from $1.52 Bn in 2022 to $6.19 Bn in 2030 with a CAGR of 19.2% for the year 2022-2030. Brazil is a country with unique opportunities for the growth of telemedicine and hence will augment the growth of the telemedicine market. Cisco and GE Healthcare are the key players in the market.
Brazil OTC Pharmaceutical Market Analysis Sample Report
The Brazil OTC pharmaceuticals market is projected to grow from $4.25 Bn in 2022 to $7.93 Bn in 2030 with a CAGR of 8.1% for the year 2022-2030. Greater accessibility of the otc drugs and switching of prescription drugs to otc drugs are the major market drivers of Brazil otc pharmaceuticals market.
Brazil Ophthalmology Therapeutics Market Analysis Sample Report
Brazil ophthalmology therapeutics market is projected to grow owing to the increasing demand for high-innovation combination therapies for the treatment of glaucoma and other eye-related disorders. The market is segmented by indication and by end users.
Brazil Retail Pharmacy Market Analysis Sample Report
Brazil's Retail Pharmacy Market is projected to grow from $25.97 Bn in 2022 to $47.70 Bn by 2030, registering a CAGR of 7.9% during the forecast period of 2022-30. The market is highly competitive, with a large number of players operating in the market, including local and international retail pharmacy chains, independent pharmacies, and online pharmacies. Drogaria Sao Paulo is one of the largest retail pharmacy chains in Brazil, with more than 1,300 stores across the country.